Valuation: Astal Laboratories Limited

Market Cap 275.92Cr 2.87Cr 2.52Cr 2.34Cr 2.15Cr 4.04Cr 4.1Cr 28Cr 11Cr 135.65Cr 11Cr 11Cr 469.02Cr P/E 2024
26.3x
P/E 2025 9.45x
Enterprise Value 287.46Cr 2.99Cr 2.62Cr 2.44Cr 2.24Cr 4.2Cr 4.27Cr 29Cr 11Cr 141.32Cr 11Cr 11Cr 488.63Cr EV / Sales 2024
1.45x
EV / Sales 2025 1.36x
Free-Float
41.06%
Yield 2024 *
-
Yield 2025 -
1 day+2.62%
1 week+1.19%
Current month-7.21%
1 month+6.53%
3 months+29.86%
6 months+1.88%
Current year-4.95%
1 week 77.5
Extreme 77.5
83.89
1 month 77.5
Extreme 77.5
91.3
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 24
Extreme 24
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 15/07/2023
Compliance Officer 32 19/04/2023
Director TitleAgeSince
Director/Board Member 55 18/08/2023
Director/Board Member 62 -
Director/Board Member - 08/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.62%+1.19%-14.86%+217.99% 3.63Cr
+1.28%+1.86%+49.12%+161.48% 1,05700Cr
+1.47%+3.76%+54.85%+53.47% 62TCr
+0.75%+1.71%+35.64%+80.78% 45TCr
+1.60%+6.25%+33.95%+29.84% 34TCr
-0.60%+1.52%+35.68%+39.76% 30TCr
-0.14%+0.60%+16.17%+17.53% 26TCr
+0.09%-2.82%-28.29%-41.71% 22TCr
+1.33%+2.65%+21.85%+59.71% 20TCr
-0.33%-3.39%+14.60%+67.05% 16TCr
Average +0.86%+0.56%+21.87%+68.59% 36.14TCr
Weighted average by Cap. +0.92%+1.57%+35.81%+77.83%

Financials

2024 2025
Net sales 24Cr 24.57L 21.58L 20.07L 18.42L 34.6L 35.13L 2.38Cr 93.11L 12Cr 92.24L 90.25L 40Cr 64Cr 66.1L 58.06L 53.99L 49.54L 93.09L 94.52L 6.41Cr 2.5Cr 31Cr 2.48Cr 2.43Cr 108.2Cr
Net income 78.47L 81.48T 71.57T 66.56T 61.07T 1L 1L 8L 3L 38.58L 3L 3L 1.33Cr 8.93Cr 9L 8L 8L 7L 13.05L 13.25L 89.89L 35.12L 4.39Cr 34.79L 34.04L 15Cr
Net Debt -5.76Cr -6L -5L -5L -4L -8L -9L -58.06L -22.68L -2.83Cr -22.47L -21.99L -9.8Cr 12Cr 11.98L 10.52L 10L 9L 16.87L 17.13L 1.16Cr 45.4L 5.67Cr 44.98L 44.01L 20Cr
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
-
Date Price Change Volume
24/26/24 82.55 +2.62% 14,858
23/26/23 ₹80.44 +1.81% 9,889
22/26/22 ₹79.01 -2.79% 9,475
21/26/21 ₹81.28 -0.67% 6,819
20/26/20 ₹81.83 +3.54% 10,244
  1. Stock Market
  2. Stocks
  3. MACINTR Stock